SCHEMBL574756

SCHEMBL574756

CC(O)C(C)(N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL164800 1.00
SCHEMBL19862759 1.00
SCHEMBL21641518 1.00
SCHEMBL6848938 1.00
SCHEMBL161194 1.00
SCHEMBL9271747 1.00
SCHEMBL594190 1.00
Hydrochloric Acid SCHEMBL31757671 0.97 CYP1A2 (0.39)
Hydrochloric Acid SCHEMBL31757860 0.97 CYP1A2 (0.39)
SCHEMBL723877 0.80 CYP2D6 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116670151-A Antibacterial cyclic peptides targeting acinetobacter and other gram negative pathogens 犹他大学研究基金会 2023-08-29 CN claimed
CN-110072860-B Compounds useful as immunomodulators 百时美施贵宝公司 2022-09-02 CN claimed
CN-108368090-B Compounds as immunomodulators 百时美施贵宝公司 2022-04-12 CN claimed
US-20160318987-A1 PROTEASE RESISTANT PEPTIDES MEDIMMUNE LIMITED (GB) 2016-11-03 US claimed
EP-3080153-A2 PROTEASE RESISTANT PEPTIDES Medimmune Limited (GB) 2016-10-19 EP claimed
WO-2015086686-A2 PROTEASE RESISTANT PEPTIDES MEDIMMUNE LIMITED (GB) 2015-06-18 WO claimed
US-20120264685-A1 SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP 1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST CADILA HEALTHCARE LIMITED (IN) 2012-10-18 US claimed
EP-2491054-A2 SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP-1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST Cadila Healthcare Limited (IN) 2012-08-29 EP claimed
US-20120040915-A1 PEPTIDES AND NANOPARTICLES FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-02-16 US claimed
WO-2011048614-A2 SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP-1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST CADILA HEALTHCARE LIMITED (IN) 2011-04-28 WO claimed
WO-2010088527-A2 PEPTIDES AND NANOPARTICLES FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2010-08-05 WO claimed
WO-2026107423-A1 ORAL PEPTIDES AND USES THEREOF FOR WEIGHT LOSS, WEIGHT MAINTENANCE, AND MANAGEMENT OF METABOLIC CONDITIONS METSERA, INC. (US) 2026-05-21 WO disclosed
EP-4626479-A1 COMPOSITIONS AND METHODS FOR PROTEIN INTERNALIZATION Lytica Therapeutics, Inc. (US) 2025-10-08 EP disclosed
US-20250074945-A1 ANTIBACTERIAL CYCLOPEPTIDES TARGETING ACINETOBACTER AND OTHER GRAM-NEGATIVE PATHOGENS UNIV UTAH RES FOUND (US) 2025-03-06 US disclosed
US-12215129-B2 Antibacterial cyclopeptides targeting acinetobacter and other gram-negative pathogens UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2025-02-04 US disclosed
CN-1351663-A Viral variants NORTH WESTER HEALTH CARE NETWO (AU) 2002-05-29 CN disclosed
WO-1999014243-A1 IMMUNOINTERACTIVE MOLECULES AND USES THEREFOR CONE ROBERT EDWARD (US) 1999-03-25 WO disclosed
US-4997985-A Alpha amino acid amide compounds which are useful intermediates in the preparation of herbicides CIBA-GEIGY CORPORATION (US) 1991-03-05 US disclosed
US-4895588-A Substituted imidazolones having herbicidal activity CIBA-GEIGY CORPORATION (US) 1990-01-23 US disclosed
US-4745124-A THIO/ESTER PEPTIDES UNIVERSITY OF MIAMI (US) 1988-05-17 US disclosed